- Home
- TXMD vs USEA Comparison
TXMD vs USEA Comparison
Compare TXMD & USEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- USEA
- Stock Information
- Founded
- TXMD 2008
- USEA 2004
- Country
- TXMD United States
- USEA Greece
- Employees
- TXMD N/A
- USEA N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- USEA Marine Transportation
- Sector
- TXMD Health Care
- USEA Consumer Discretionary
- Exchange
- TXMD Nasdaq
- USEA Nasdaq
- Market Cap
- TXMD 17.9M
- USEA 20.0M
- IPO Year
- TXMD N/A
- USEA N/A
- Fundamental
- Price
- TXMD $1.41
- USEA $2.10
- Analyst Decision
- TXMD
- USEA Strong Buy
- Analyst Count
- TXMD 0
- USEA 1
- Target Price
- TXMD N/A
- USEA $6.00
- AVG Volume (30 Days)
- TXMD 17.4K
- USEA 40.8K
- Earning Date
- TXMD 11-12-2024
- USEA 11-26-2024
- Dividend Yield
- TXMD N/A
- USEA 14.29%
- EPS Growth
- TXMD N/A
- USEA N/A
- EPS
- TXMD N/A
- USEA 0.85
- Revenue
- TXMD $1,596,000.00
- USEA $46,276,000.00
- Revenue This Year
- TXMD $605.07
- USEA $36.03
- Revenue Next Year
- TXMD $1.11
- USEA $11.85
- P/E Ratio
- TXMD N/A
- USEA $2.48
- Revenue Growth
- TXMD N/A
- USEA 86.18
- 52 Week Low
- TXMD $1.38
- USEA $2.05
- 52 Week High
- TXMD $3.07
- USEA $3.00
- Technical
- Relative Strength Index (RSI)
- TXMD 19.09
- USEA 31.62
- Support Level
- TXMD $1.47
- USEA $2.23
- Resistance Level
- TXMD $1.58
- USEA $2.18
- Average True Range (ATR)
- TXMD 0.06
- USEA 0.10
- MACD
- TXMD -0.01
- USEA -0.01
- Stochastic Oscillator
- TXMD 13.23
- USEA 14.29
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About USEA United Maritime Corporation
United Maritime Corp operates as a shipping company currently specializing in the seaborne transportation of dry bulk commodities. It currently operates one LR2 tanker vessel and three Capesize dry bulk vessels, two Kamsarmax dry bulk vessels, and three Panamax dry bulk vessels, with an aggregate cargo-carrying capacity of approximately 1,004,289 dwt.